4.8 Article

Vaccines with MF59 Adjuvant Expand the Antibody Repertoire to Target Protective Sites of Pandemic Avian H5N1 Influenza Virus

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Microbiology

Emergence of European Avian Influenza Virus-Like H1N1 Swine Influenza A Viruses in China

Jinhua Liu et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2009)

Article Immunology

Safety and Immunogenicity of Multiple and Higher Doses of an Inactivated Influenza A/H5N1 Vaccine

John H. Beigel et al.

JOURNAL OF INFECTIOUS DISEASES (2009)

Article Multidisciplinary Sciences

Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine

Grazia Galli et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Multidisciplinary Sciences

Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels

Grazia Galli et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Immunology

Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults

David I. Bernstein et al.

JOURNAL OF INFECTIOUS DISEASES (2008)

Letter Medicine, General & Internal

Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1

Iain Stephenson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Medicine, General & Internal

Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza

Cameron P. Simmons et al.

PLOS MEDICINE (2007)

Article Medicine, General & Internal

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine

JJ Treanor et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Letter Infectious Diseases

Development and evaluation of influenza pandemic vaccines

I Stephenson et al.

LANCET INFECTIOUS DISEASES (2006)